Search all trials

Find therapies in clinical trials near you – page 6

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Bronchiectasis

Not recruiting

Investigational

Study on the Effects of Itepekimab for Patients with Non-Cystic Fibrosis Bronchiectasis

Investigational

France

Participants:18–64 years · 65+ years
Substances:Itepekimab

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study on Reducing Hormone Therapy Duration with Exemestane, Letrozole, and Anastrozole in Post-Menopausal Women with Low-Risk Hormone-Sensitive Breast Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study of palbociclib with hormone therapy guided by ESR1 mutation monitoring in patients with ER-positive, HER2-negative metastatic breast cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Vaginal infection

Not recruiting

Investigational

Study on the Effectiveness and Safety of BGY-1601-VT for Women with Acute Vaginal Infections, Including Bacterial Vaginosis and Yeast Infections

Investigational

France

Participants:18–64 years
Substances:Lactobacillus Rhamnosus, Strain Lcr35, Live

Contact Research Centre

Breast cancer metastatic+2

Not recruiting

Registered drugNo placebo

Study on Detecting Untreated Brain Metastases in Lung, Breast, and Melanoma Cancer Patients Using Fluorodopa (18F)

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Fluorodopa (18F)

Contact Research Centre

Glioblastoma multiforme+1

Not recruiting

Registered drugNo placebo

Study on Early Temozolomide Treatment for Adults with Glioblastoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Temozolomide

Contact Research Centre

Gastrointestinal carcinoma

Not recruiting

Registered drug

Study on the Effects of Methylprednisolone and Sodium Chloride in Patients Undergoing Surgery for Digestive Cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study on Vemurafenib for Patients with Advanced Cancers with BRAF Gene Changes

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Vemurafenib

Contact Research Centre

Type 1 diabetes mellitus

Not recruiting

Registered drug

Study on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy

Registered drug

France

Participants:0–17 years · 18–64 years

Contact Research Centre

Follicular lymphoma+1

Not recruiting

Registered drug

Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Anal squamous cell carcinoma

Not recruiting

Registered drugNo placebo

Study Comparing Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil to Standard Treatment for Patients with Advanced Anal Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Relapsing-remitting multiple sclerosis

Not recruiting

Registered drugNo placebo

Study Comparing Rituximab and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo

France

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

Find therapies in clinical trials near you – page 6

80 trials match your criteria

Bronchiectasis

Study on the Effects of Itepekimab for Patients with Non-Cystic Fibrosis Bronchiectasis

Hormone receptor positive HER2 negative breast cancer

Study on Reducing Hormone Therapy Duration with Exemestane, Letrozole, and Anastrozole in Post-Menopausal Women with Low-Risk Hormone-Sensitive Breast Cancer

Hormone receptor positive HER2 negative breast cancer

Study of palbociclib with hormone therapy guided by ESR1 mutation monitoring in patients with ER-positive, HER2-negative metastatic breast cancer

Vaginal infection

Study on the Effectiveness and Safety of BGY-1601-VT for Women with Acute Vaginal Infections, Including Bacterial Vaginosis and Yeast Infections

Breast cancer metastatic+2

Study on Detecting Untreated Brain Metastases in Lung, Breast, and Melanoma Cancer Patients Using Fluorodopa (18F)

Glioblastoma multiforme+1

Study on Early Temozolomide Treatment for Adults with Glioblastoma

Gastrointestinal carcinoma

Study on the Effects of Methylprednisolone and Sodium Chloride in Patients Undergoing Surgery for Digestive Cancer

Neoplasm

Study on Vemurafenib for Patients with Advanced Cancers with BRAF Gene Changes

Type 1 diabetes mellitus

Study on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy

Follicular lymphoma+1

Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Anal squamous cell carcinoma

Study Comparing Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil to Standard Treatment for Patients with Advanced Anal Cancer

Relapsing-remitting multiple sclerosis

Study Comparing Rituximab and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.